A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT05284175 · UNKNOWN
Trial details
- NCT number
- NCT05284175
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2023-08-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.